These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36920813)

  • 21. A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.
    O'Hanlon CE; Parthan A; Kruse M; Cartier S; Stollenwerk B; Jiang Y; Caloyeras JP; Crittenden DB; Barron R
    Clin Ther; 2017 Jul; 39(7):1276-1290. PubMed ID: 28629610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of the management of osteoporosis in the aging female population.
    Amin U; McPartland A; O'Sullivan M; Silke C
    Womens Health (Lond); 2023; 19():17455057231176655. PubMed ID: 37218715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
    McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
    Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2020 Jul; 62(1602):105-112. PubMed ID: 32728009
    [No Abstract]   [Full Text] [Related]  

  • 25. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.
    Leder BZ
    Curr Osteoporos Rep; 2017 Apr; 15(2):110-119. PubMed ID: 28303448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Practice. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 Jan; 374(3):254-62. PubMed ID: 26789873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for the optimal use of bone forming agents in osteoporosis.
    Veronese N; Briot K; Guañabens N; Albergaria BH; Alokail M; Al-Daghri N; Bemden AB; Bruyère O; Burlet N; Cooper C; Curtis EM; Ebeling PR; Halbout P; Hesse E; Hiligsmann M; Camargos BM; Harvey NC; Perez AD; Radermecker RP; Reginster JY; Rizzoli R; Siggelkow H; Cortet B; Brandi ML
    Aging Clin Exp Res; 2024 Aug; 36(1):167. PubMed ID: 39120740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapeutic targets for osteoporosis.
    Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
    Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review.
    Li N; Beaudart C; Cauley JA; Ing SW; Lane NE; Reginster JY; Silverman S; Singer AJ; Hiligsmann M
    Pharmacoeconomics; 2023 Apr; 41(4):363-391. PubMed ID: 36738425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.
    Liu J; Laster A; Xu X; Guo H; Oates M; Gandra SR
    J Bone Miner Res; 2021 Dec; 36(12):2309-2316. PubMed ID: 34490946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Basics of Bone Physiology, Healing, and Osteoporosis.
    Dimar JR; Lane JM; Lehman RA; Anderson PA
    Instr Course Lect; 2021; 70():527-536. PubMed ID: 33438933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis in premenopausal women.
    Langdahl BL
    Curr Opin Rheumatol; 2017 Jul; 29(4):410-415. PubMed ID: 28394826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Osteoporosis Screening and Management.
    Anam AK; Insogna K
    Med Clin North Am; 2021 Nov; 105(6):1117-1134. PubMed ID: 34688418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing osteoporosis in ulcerative colitis: something new?
    Piodi LP; Poloni A; Ulivieri FM
    World J Gastroenterol; 2014 Oct; 20(39):14087-98. PubMed ID: 25339798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
    Miller PD; Derman RJ
    Osteoporos Int; 2010 Nov; 21(11):1793-802. PubMed ID: 20309524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.